Skip to Content

Lidocaine with Epinephrine Injection

Last Updated: March 26, 2018
Status: Resolved

Lidocaine with Epinephrine Injection

Products Affected - Description
  • Lidocaine (with epinephrine 1:100,000) injection, Pfizer

1%, 20 mL vial, 100 count (NDC 00409-3178-01)
1%, 30 mL vial, 100 count (NDC 00409-3178-02)
1%, 50 mL vial, 100 count (NDC 00409-3178-03)
2%, 20 mL vial, 100 count (NDC 00409-3182-01)
2%, 30 mL vial, 100 count (NDC 00409-3182-02)
2%, 50 mL vial, 100 count (NDC 00409-3182-03)
 
Lidocaine (with epinephrine 1:200,000) injection, Pfizer
0.5%, 50 mL vial, 100 count (NDC 00409-3177-01)
1.5%, 30 mL vial, 25 count (NDC 00409-3181-01)
2%, 20 mL vial, 25 count (NDC 00409-3183-01)
 
Xylocaine (with epinephrine 1:200,000) injection, Fresenius Kabi
0.5%, 50 mL vial, 25 count (NDC 63323-0481-57)
1%, 10 mL vial, 25 count (NDC 63323-0482-17)
1%, 20 mL vial, 25 count (NDC 63323-0482-27)
1%, 50 mL vial, 25 count (NDC 63323-0482-57)
2%, 20 mL vial, 25 count (NDC 63323-0483-27)
2%, 50 mL vial, 25 count (NDC 63323-0483-57)
 
Xylocaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi
1%, 10 mL vial, 25 count (NDC 63323-0487-17)
1%, 30 mL vial, sterile-pack 5 count (NDC 63323-0487-31)
1%, 30 mL vial, 25 count (NDC 63323-0487-37)
1.5%, 10 mL vial, 25 count (NDC 63323-0488-17)
1.5%, 30 mL vial, sterile-pack 5 count (NDC 63323-0488-31)
1.5%, 30 mL vial, 25 count (NDC 63323-0488-37)
2%, 10 mL vial, 25 count (NDC 63323-0489-17)
2%, 20 mL vial, sterile-pack 5 count (NDC 63323-0489-21)
2%, 20 mL vial, 25 count (NDC 63323-0489-27)
Reason for the Shortage
    • Fresenius Kabi has Xylocaine with epinephrine presentations on shortage due to increased demand for the product and manufacturing delays.
    • Pfizer has lidocaine with epinephrine presentations on shortage due to manufacturing delays.
Available Products
  • Lidocaine (with epinephrine 1:200,000) injection, Pfizer
    1.5%, 5 mL glass ampule, 10 count (NDC 00409-1209-01)

Estimated Resupply Dates

    • Pfizer has 0.5% lidocaine with epinephrine (1:200,000) 50 mL on back order and the company estimates a release date of mid-May 2018. The 1% lidocaine with epinephrine (1:100,000) 20 mL vials are on back order and the company estimates a release date of late-May 2018. The 1% lidocaine with epinephrine (1:100,000) 30 mL are on back order and the company estimates a release date in mid-April 2018. The 1% lidocaine with epinephrine (1:100,000) 50 mL vials are on back order and the company estimates a release date of late-March 2018. The 1.5% lidocaine with epinephrine (1:200,000) 30 mL vials are on back order and the company estimates a release date of September 2018. The 2% lidocaine with epinephrine (1:200,000) 20 mL vials are on back order and the company estimates a release date of March 2018. The 2% lidocaine with epinephrine (1:100,000) 20 mL, 30 mL, and 50 mL vials are on back order and the company estimates a release date of June 2018 for the 20 mL and 30 mL vials and early-April 2018 for the 50 mL vials.
    • Fresenius Kabi has 0.5% Xylocaine with epinephrine (1:200,000) 50 mL vials on back order and the company estimates a release date of early- to mid-April 2018. The 1% Xylocaine with epinephrine (1:200,000) 10 mL vials are on back order and the company cannot estimate a release date. The 1% Xylocaine with epinephrine (1:200,000) 20 mL and 50 mL vials are on back order and the company estimates a release date of early-April 2018. The 1% Xylocaine-MPF with epinephrine (1:200,000) 10 mL and 30 mL vials are on back order and the company estimates a release date of late-April 2018 for the 10 mL vials and late-March 2018 for the 30 mL vials. The 1% Xylocaine-MPF with epinephrine (1:200,000) 30 mL vials in sterile packs are on back order and the company cannot estimate a release date. The 1.5% Xylocaine-MPF with epinephrine (1:200,000) 30 mL vials are on back order and the company estimates a release date of early- to mid-April 2018. The 1.5% Xylocaine-MPF with epinephrine (1:200,000) 10 mL regular vials and 30 mL vials in sterile packs are on back order and the company cannot estimate a release date. The 2% Xylocaine with epinephrine (1:200,000) 20 mL vials are on back order and the company and the company estimates a release date of late-March 2018. The 2% Xylocaine with epinephrine (1:200,000) 50 mL vials are on back order and the company estimates a release date of mid-May 2018. The 2% Xylocaine-MPF with epinephrine (1:200,000) 10 mL and 20 mL vials are on back order and the company estimates a release date of late-March 2018 for the 10 mL vials and early- to mid-April 2018 for the 20 mL vials. The 2% Xylocaine-MPF with epinephrine (1:200,000) 20 mL vials in sterile packs are on back order and the company cannot estimate a release date.

Updated

March 26, 22, 13 and 7, February 20 and 12, January 22, 2018; December 29, 11 and 6, November 22 and 2, September 30 and 8, August 25 and 17, July 31 and 7, June 22, May 15, April 30, March 21, February 21, January 27, 13 and 5, 2017; December 20, 9 and 2, November 11, May 26, 2016; August 6, July 17, June 25, May 11, April 15, March 27, February 20, January 23 and 7, 2015; December 18, November 20, October 31, September 10, August 28, July 25, June 11, May 28, April 9, March 27, February 27, January 21, 14 and 6, 2014; December 13, November 27 and 15, October 31, September 18, August 13, July 1, June 26, 10 and 6, May 9, April 23 and 9, March 27, February 28 and 5, January 16, 2013; December 12, November 9, October 25 and 17, August 22 and 9, June 21, May 30, April 16, March 7, February 22 and 8, January 25 and 3, 2012; December 16, 2011, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide